会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明授权
    • Microfluidic particle-analysis systems
    • 微流控粒子分析系统
    • US07452726B2
    • 2008-11-18
    • US10734963
    • 2003-12-11
    • Hou-Pu ChouAntoine DaridonKevin FarrellBrian FowlerYish-Hann LiauIan D. MangerHany Ramez NassefWilliam Throndset
    • Hou-Pu ChouAntoine DaridonKevin FarrellBrian FowlerYish-Hann LiauIan D. MangerHany Ramez NassefWilliam Throndset
    • G01N35/00G01N33/48G01N1/10G01N15/06G01N33/00
    • G01N35/00B01L3/502746B01L3/502753B01L3/502761B01L2200/0636B01L2200/0647B01L2200/0652B01L2200/0668B01L2200/10B01L2200/12B01L2300/0645B01L2300/0681B01L2300/0861B01L2300/0867B01L2300/087B01L2300/0887B01L2300/123B01L2400/0409B01L2400/0481B01L2400/0655G01N15/1456G01N15/1468G01N15/1484G01N2015/0288G01N2015/1075G01N2015/149G01N2015/1493Y10T436/11Y10T436/2575
    • The invention provides systems, including apparatus, methods, and kits, for the microfluidic manipulation and/or detection of particles, such as cells and/or beads. The invention provides systems, including apparatus, methods, and kits, for the microfluidic manipulation and/or analysis of particles, such as cells, viruses, organelles, beads, and/or vesicles. The invention also provides microfluidic mechanisms for carrying out these manipulations and analyses. These mechanisms may enable controlled input, movement/positioning, retention/localization, treatment, measurement, release, and/or output of particles. Furthermore, these mechanisms may be combined in any suitable order and/or employed for any suitable number of times within a system. Accordingly, these combinations may allow particles to be sorted, cultured, mixed, treated, and/or assayed, among others, as single particles, mixed groups of particles, arrays of particles, heterogeneous particle sets, and/or homogeneous particle sets, among others, in series and/or in parallel. In addition, these combinations may enable microfluidic systems to be reused. Furthermore, these combinations may allow the response of particles to treatment to be measured on a shorter time scale than was previously possible. Therefore, systems of the invention may allow a broad range of cell and particle assays, such as drug screens, cell characterizations, research studies, and/or clinical analyses, among others, to be scaled down to microfluidic size. Such scaled-down assays may use less sample and reagent, may be less labor intensive, and/or may be more informative than comparable macrofluidic assays.
    • 本发明提供了用于微流体操纵和/或检测诸如细胞和/或珠粒的装置,方法和试剂盒的系统。 本发明提供了用于微粒操作和/或分析颗粒例如细胞,病毒,细胞器,珠粒和/或囊泡的装置,方法和试剂盒的系统。 本发明还提供用于进行这些操作和分析的微流体机理。 这些机制可以实现颗粒的控制输入,运动/定位,保留/定位,处理,测量,释放和/或输出。 此外,这些机制可以以任何合适的顺序组合和/或在系统内任何适当次数使用。 因此,这些组合可以允许将粒子分类,培养,混合,处理和/或测定为单粒子,粒子的混合组,粒子阵列,非均匀粒子组和/或均匀粒子组,其中 其他,串联和/或并行。 此外,这些组合可以使微流体系统能够重复使用。 此外,这些组合可以允许在比以前可能的更短的时间尺度上测量颗粒对治疗的反应。 因此,本发明的系统可以允许广泛范围的细胞和颗粒测定,例如药物筛选,细胞特征化,研究研究和/或临床分析等,以缩小到微流体大小。 这种按比例缩小的测定可能使用较少的样品和试剂,可能较少的劳动密集型和/或可能比可比较的大流控测定更具信息性。
    • 10. 发明授权
    • Microfluidic particle-analysis systems
    • 微流控粒子分析系统
    • US07312085B2
    • 2007-12-25
    • US10405953
    • 2003-04-01
    • Hou-Pu ChouAntoine DaridonKevin FarrellBrian FowlerYish-Hann LiauIan D. MangerHany Ramez NassefWilliam Throndset
    • Hou-Pu ChouAntoine DaridonKevin FarrellBrian FowlerYish-Hann LiauIan D. MangerHany Ramez NassefWilliam Throndset
    • G01N35/00G01N33/48G01N1/10G01N15/06G01N33/00
    • G01N35/00B01L3/502746B01L3/502753B01L3/502761B01L2200/0636B01L2200/0647B01L2200/0652B01L2200/0668B01L2200/10B01L2200/12B01L2300/0645B01L2300/0681B01L2300/0861B01L2300/0867B01L2300/087B01L2300/0887B01L2300/123B01L2400/0409B01L2400/0481B01L2400/0655G01N15/1456G01N15/1468G01N15/1484G01N2015/0288G01N2015/1075G01N2015/149G01N2015/1493Y10T436/11Y10T436/2575
    • The invention provides systems, including apparatus, methods, and kits, for the microfluidic manipulation and/or detection of particles, such as cells and/or beads. The invention provides systems, including apparatus, methods, and kits, for the microfluidic manipulation and/or analysis of particles, such as cells, viruses, organelles, beads, and/or vesicles. The invention also provides microfluidic mechanisms for carrying out these manipulations and analyses. These mechanisms may enable controlled input, movement/positioning, retention/localization, treatment, measurement, release, and/or output of particles. Furthermore, these mechanisms may be combined in any suitable order and/or employed for any suitable number of times within a system. Accordingly, these combinations may allow particles to be sorted, cultured, mixed, treated, and/or assayed, among others, as single particles, mixed groups of particles, arrays of particles, heterogeneous particle sets, and/or homogeneous particle sets, among others, in series and/or in parallel. In addition, these combinations may enable microfluidic systems to be reused. Furthermore, these combinations may allow the response of particles to treatment to be measured on a shorter time scale than was previously possible. Therefore, systems of the invention may allow a broad range of cell and particle assays, such as drug screens, cell characterizations, research studies, and/or clinical analyses, among others, to be scaled down to microfluidic size. Such scaled-down assays may use less sample and reagent, may be less labor intensive, and/or may be more informative than comparable macrofluidic assays.
    • 本发明提供了用于微流体操纵和/或检测诸如细胞和/或珠粒的装置,方法和试剂盒的系统。 本发明提供了用于微粒操作和/或分析颗粒例如细胞,病毒,细胞器,珠粒和/或囊泡的装置,方法和试剂盒的系统。 本发明还提供用于进行这些操作和分析的微流体机理。 这些机制可以实现颗粒的控制输入,运动/定位,保留/定位,处理,测量,释放和/或输出。 此外,这些机制可以以任何合适的顺序组合和/或在系统内任何适当次数使用。 因此,这些组合可以允许将粒子分类,培养,混合,处理和/或测定为单粒子,粒子的混合组,粒子阵列,非均匀粒子组和/或均匀粒子组,其中 其他,串联和/或并行。 此外,这些组合可以使微流体系统能够重复使用。 此外,这些组合可以允许在比以前可能的更短的时间尺度上测量颗粒对治疗的反应。 因此,本发明的系统可以允许广泛范围的细胞和颗粒测定,例如药物筛选,细胞特征化,研究研究和/或临床分析等,以缩小到微流体大小。 这种按比例缩小的测定可能使用较少的样品和试剂,可能较少的劳动密集型和/或可能比可比较的大流控测定更具信息性。